IL33 and obesity disorder: These studies indicate that, unlike sST2, IL-33 levels do not significantly decrease after surgery, suggesting that while IL-33 may potentially serve as a marker of obesity-related inflammation, it appears to be relatively unaffected by weight loss induced by gastric bypass surgery.